Literature DB >> 31111350

ASO Author Reflections: Malignant/Borderline Phyllodes Tumors Without Uniformly Poor Histologic Features Have an Excellent Prognosis.

Philip M Spanheimer1, Andrea V Barrio2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31111350      PMCID: PMC6864261          DOI: 10.1245/s10434-019-07459-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  5 in total

1.  Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program.

Authors:  O Kenneth Macdonald; Christopher M Lee; Jonathan D Tward; Craig D Chappel; David K Gaffney
Journal:  Cancer       Date:  2006-11-01       Impact factor: 6.860

2.  Radiation therapy for malignant phyllodes tumor of the breast: An analysis of SEER data.

Authors:  Yi-Jun Kim; Kyubo Kim
Journal:  Breast       Date:  2016-12-22       Impact factor: 4.380

3.  Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast.

Authors:  Philip M Spanheimer; Melissa P Murray; Emily C Zabor; Michelle Stempel; Monica Morrow; Kimberly J Van Zee; Andrea V Barrio
Journal:  Ann Surg Oncol       Date:  2019-02-19       Impact factor: 5.344

Review 4.  Phyllodes tumours of the breast: a consensus review.

Authors:  Benjamin Y Tan; Geza Acs; Sophia K Apple; Sunil Badve; Ira J Bleiweiss; Edi Brogi; José P Calvo; David J Dabbs; Ian O Ellis; Vincenzo Eusebi; Gelareh Farshid; Stephen B Fox; Shu Ichihara; Sunil R Lakhani; Emad A Rakha; Jorge S Reis-Filho; Andrea L Richardson; Aysegul Sahin; Fernando C Schmitt; Stuart J Schnitt; Kalliopi P Siziopikou; Fernando A Soares; Gary M Tse; Anne Vincent-Salomon; Puay Hoon Tan
Journal:  Histopathology       Date:  2016-01       Impact factor: 5.087

5.  Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998-2009.

Authors:  Jennifer L Gnerlich; Richelle T Williams; Katherine Yao; Nora Jaskowiak; Swati A Kulkarni
Journal:  Ann Surg Oncol       Date:  2013-12-04       Impact factor: 5.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.